Wall Street Associates’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Wall Street Associates’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-27,460	Closed	-$288K	–	241
2016 Q1	$288K	Sell	27,460 -42,170	-61%	-$838K	0.12%	185
2015 Q4	$2.05M	Hold	69,630	–	–	0.58%	55
2015 Q3	$2.2M	Sell	69,630 -51,910	-43%	-$2.48M	0.42%	77
2015 Q2	$7.2M	Sell	121,540 -2,160	-2%	-$152K	0.68%	48
2015 Q1	$13.2M	Sell	123,700 -2,250	-2%	-$214K	1.25%	11
2014 Q4	$11.8M	Buy	125,950 +9,780	+8%	+$933K	1.13%	11
2014 Q3	$8.92M	Sell	116,170 -6,330	-5%	-$498K	0.92%	22
2014 Q2	$11M	Buy	+122,500	New	+$7.51M	0.94%	21

Other funds holding PTX

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Globeflex Capital San Diego, California $783M AUM 81.58% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Wall Street Associates's PTX Position: Q2 2016 in Review

Wall Street Associates sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 27,460 shares — an estimated $288K sold.

Wall Street Associates first reported a position in PTX in Q2 2014 and held it in 8 quarters. The position peaked at $13.2M in Q1 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

Wall Street Associates reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
Wall Street Associates sold 27,460 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $288K.
Wall Street Associates first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 8 quarters.
Wall Street Associates's Pernix Therapeutics Holdings, Inc. position peaked at $13.2M in Q1 2015.
56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on Wall Street Associates's 13F filing for Q2 2016, filed 12 Aug 2016.